Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1971 Apr;8(4):543–550.

Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogenic and for autologous lymphocytes

P Stastny, M Ziff
PMCID: PMC1712965  PMID: 5103550

Abstract

When single random serums from sixty patients with systemic lupus erythematosus (SLE) were examined for cytotoxicity against allogeneic lymphocytes, thirty-six or 60% were found to be cytotoxic. In controls, consisting of eighteen blood bank donors, forty-five clinic patients matched to the SLE group, and 366 multiparous women, cytotoxicity was found in 0, 4 and 12% respectively. When 151 serums from twenty SLE patients were tested against their own lymphocytes, twenty-four serums from twelve patients gave autologous reactions. Cytotoxicity of SLE serums for both allogeneic and autologous lymphocytes was complement dependent and could be specifically absorbed with reactive lymphocytes, suggesting that the factor responsible for cytotoxicity was an antibody. Since activity was present at 37°C, cytotoxicity may be assumed to be manifest in vivo. These antibodies may play a role in the leukopenia of SLE and may also be responsible for other manifestations of multisystem disease.

Full text

PDF
543

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DAUSSET J., BRECY H. Test direct de consommation de l'antiglobuline sur les leucocytes et les plaquettes de certains malades atteints de pancytopénies idiopathiques. Vox Sang. 1958 May;3(3):197–203. doi: 10.1111/j.1423-0410.1958.tb03613.x. [DOI] [PubMed] [Google Scholar]
  2. DAUSSET J., COLOMBANI J., COLOMBANI M. Study of leukopenias and thrombocytopenias by the direct antiglobulin consumption test on leukocytes and/or platelets. Blood. 1961 Dec;18:672–690. [PubMed] [Google Scholar]
  3. ENGELFRIET C. P., EIJSVOOGEL V. P. CYTOTOXIC ISO-ANTIBODIES AGAINST LEUCOCYTES. Vox Sang. 1965 Mar-Apr;10:228–233. doi: 10.1111/j.1423-0410.1965.tb04345.x. [DOI] [PubMed] [Google Scholar]
  4. ENGELFRIET C. P., VAN LOGHEM J. J. Studies on leucocyte iso- and auto-antibodies. Br J Haematol. 1961 Apr;7:223–238. doi: 10.1111/j.1365-2141.1961.tb00331.x. [DOI] [PubMed] [Google Scholar]
  5. Kissmeyer-Nielsen F., Olsen S., Petersen V. P., Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet. 1966 Sep 24;2(7465):662–665. doi: 10.1016/s0140-6736(66)92829-7. [DOI] [PubMed] [Google Scholar]
  6. MICHAEL S. R., VURAL I. L., BASSEN F. A., SCHAEFER L. The hematologic aspects of disseminated (systemic) lupus erythematosus. Blood. 1951 Nov;6(11):1059–1072. [PubMed] [Google Scholar]
  7. MIESCHER P. Leucopénie chronique par auto-anticorps. Acta Haematol. 1954 Mar;11(3):152–167. doi: 10.1159/000204544. [DOI] [PubMed] [Google Scholar]
  8. Mittal K. K., Mickey M. R., Singal D. P., Terasaki P. I. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation. 1968 Nov;6(8):913–927. doi: 10.1097/00007890-196811000-00006. [DOI] [PubMed] [Google Scholar]
  9. Mittal K. K., Rossen R. D., Sharp J. T., Lidsky M. D., Butler W. T. Lymphocyte cytotoxic antibodies in systemic lupus erythematosus. Nature. 1970 Mar 28;225(5239):1255–1256. doi: 10.1038/2251255a0. [DOI] [PubMed] [Google Scholar]
  10. NELKEN D. Nature of the coating globulin causing a positive antiglobulin consumption test. Nature. 1961 Sep 9;191:1110–1111. doi: 10.1038/1911110a0. [DOI] [PubMed] [Google Scholar]
  11. PAYNE R., ROLFS M. R. Fetomaternal leukocyte incompatibility. J Clin Invest. 1958 Dec;37(12):1756–1763. doi: 10.1172/JCI103768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. PIZARRO O., HOECKER G., RUBINSTEIN P., RAMOS A. The distribution in the tissues and the development of H-2 antigens of the mouse. Proc Natl Acad Sci U S A. 1961 Dec 15;47:1900–1907. doi: 10.1073/pnas.47.12.1900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Patel R., Terasaki P. I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969 Apr 3;280(14):735–739. doi: 10.1056/NEJM196904032801401. [DOI] [PubMed] [Google Scholar]
  14. Shanbrom E., Feingold E., Shepherd L., Walford R. L. Antisera for tissue-typing: the production of cytotoxic and agglutinating antibodies following intradermal leukocyte injections in man. Blood. 1968 Sep;32(3):402–411. [PubMed] [Google Scholar]
  15. TULLIS J. L. Leukocyte and thromboycte antibodies. Current concepts of their origin, identity, and significance. JAMA. 1962 Jun 16;180:958–964. [PubMed] [Google Scholar]
  16. VAN LOGHEM J. J., Jr, VAN DER HART M., HIJMANS W., SCHUIT H. R. The incidence and significance of complete and incomplete white cell antibodies with special reference to the use of the Coombs consumption test. Vox Sang. 1958 May;3(3):203–223. doi: 10.1111/j.1423-0410.1958.tb03614.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES